Filter
2468
Filtered Results: 2468
Text search:
drug-resistance
infections
Featured
Recommendations
277
New Publications
650
Language
Document type
No document type
1400
Guidelines
395
Studies & Reports
377
Manuals
104
Strategic & Response Plan
82
Fact sheets
41
Training Material
37
Situation Updates
13
Infographics
10
Brochures
3
Resource Platforms
3
Online Courses
2
Videos
1
Countries / Regions
India
137
South Africa
73
Kenya
71
Global
68
Western and Central Europe
67
Ethiopia
55
Tanzania
43
Africa
42
Uganda
42
Eastern Europe
42
Nepal
41
Nigeria
37
Zambia
36
Liberia
32
Latin America and the Carribbean
31
Malawi
30
Sierra Leone
29
Rwanda
26
Ghana
25
Bangladesh
24
Namibia
24
Myanmar / Burma
24
Philippines
23
Asia
22
South–East Asia Region
22
Cambodia
20
Zimbabwe
18
Lesotho
17
Ukraine
16
Russia
15
Senegal
13
Indonesia
13
Mozambique
12
Cameroon
11
Congo, Democratic Republic of
11
Botswana
10
Albania
8
Burkina Faso
8
West and Central Africa
8
Eswatini/ Swaziland
8
Thailand
7
East and Southern Africa
7
Pakistan
7
Colombia
6
Syria
6
USA
6
Haiti
6
Venezuela
6
Middle East and North Africa
6
Eastern Europe and Central Asia
6
Argentina
6
China
5
Guinea
5
Georgia
5
Tajikistan
4
Benin
4
Germany
4
Western Pacific Region
4
Brazil
4
Sudan
4
North Macedonia
3
Iran
3
Laos
3
Peru
3
Jordan
3
North America
3
Lebanon
3
Vietnam
3
Central African Republic
3
Bhutan
3
South Sudan
3
Iraq
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
El Salvador
2
Estonia
2
Afghanistan
2
Morocco
2
Armenia
2
Saudi Arabia
2
Paraguay
2
Gabon
2
Uruguay
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Moldova
2
Sri Lanka
2
Yemen
2
Mali
2
Madagascar
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Guinea-Bissau
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Oman
1
Nicaragua
1
Egypt
1
Greece
1
Honduras
1
Angola
1
Libya
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
860
Clinical Guidelines
267
Public Health
99
Women & Child Health
77
Key Resources
64
Capacity Building
33
Pharmacy & Technologies
31
Annual Report MEDBOX
1
Toolboxes
TB
444
HIV
325
AMR
317
NTDs
112
COVID-19
81
Rapid Response
60
Mental Health
56
Pharmacy
54
Caregiver
45
Planetary Health
41
Malaria
35
Ebola & Marburg
32
Refugee
27
Global Health Education
27
NCDs
20
Health Financing Toolbox
18
Polio
16
Conflict
13
Cholera
12
Natural Hazards
7
Disability
7
Zika
4
Specific Hazards
3
Social Ethics
1
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
The growing understanding of how sequence information can contribute to improved public health is driving global investments in sequencing facilities and programmes. The falling cost and complexity of generating GSD provides opportunities for expanding sequencing capacity; however, challenges to wid...
2nd edition. This second edition builds on the experience of more than 10 years of SMC deployment, and reflects changes introduced in the WHO guidelines for malaria, 3 June 2022. The goal of this publication is to share these best practices to improve SMC implementation, coverage, and monitoring and...
Third edition.
The main changes within the third edition of the JEE tool include the split of the technical area National legislation, policy, and financing into two technical areas (Legal instruments and Financing); the drop of the technical area previously titled Reporting and the move of indicat...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
This helpdesk report seeks to establish what lessons have been learnt from the current and previous Ebola outbreaks. It recommends good practice and makes suggestions based on the evidence for good practice and preparedness to reduce transmission and prevent further risk and exposure in affected cou...
